Showing results (61-70 of 378) with videos related to

Sort By:
Pageof 38
American Journal of Hematology|December 1, 1995
Light-heavy chain deposition disease progressing to multiple myelomaD Daliani, D Weber, R Alexanian
American Journal of Clinical Oncology|June 1, 1991
Alpha-interferon combination therapy of resistant myelomaR Alexanian, B Barlogie, J Gutterman
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 19, 2015
Specific combinations of the chromatin-modifying enzyme modulators significantly attenuate glioblastoma cell proliferation and viability while exerting minimal effect on normal adult stem cells growthArshak R Alexanian, Yi-Wen Huang
Assay and Drug Development Technologies|February 23, 2022
Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the AccuracyHeidi Marie Stoellinger, Arshak R Alexanian
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaBA R Alexanian, J R Bamburg
Archives of Internal Medicine|August 1, 1990
Renal failure in multiple myeloma. Pathogenesis and prognostic implicationsR Alexanian, B Barlogie, D Dixon
Archives of Internal Medicine|September 1, 1988
Prognosis of asymptomatic multiple myelomaR Alexanian, B Barlogie, D Dixon
American Journal of Hematology|February 1, 1990
VAD-based regimens as primary treatment for multiple myelomaR Alexanian, B Barlogie, S Tucker
Neuroscience|April 5, 2003
Differentiating adult hippocampal stem cells into neural crest derivativesA R Alexanian, M Sieber-Blum
Pageof 38